世界の抗糖尿病薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Anti-Diabetic Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0381 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、抗糖尿病薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビグアニド、スルホニル尿素、メグリチニド、チアゾリジンジオン、ジペプチジルペプチダーゼIV阻害剤、α-グルコシダーゼ阻害剤）、用途別市場規模（I型糖尿病、II型糖尿病、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・抗糖尿病薬の市場動向 ・企業の競争状況、市場シェア ・抗糖尿病薬の種類別市場規模（ビグアニド、スルホニル尿素、メグリチニド、チアゾリジンジオン、ジペプチジルペプチダーゼIV阻害剤、α-グルコシダーゼ阻害剤） ・抗糖尿病薬の用途別市場規模（I型糖尿病、II型糖尿病、その他） ・抗糖尿病薬の北米市場規模2016-2027（アメリカ、カナダ） ・抗糖尿病薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗糖尿病薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗糖尿病薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗糖尿病薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Astra Zeneca、Boehringer Ingelheim、Eli Lilly、Johnson & Johnson、Merck、Novartis、Novo Nordisk、Sanofi、Teva Pharmaceutical Industries） ・結論

The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally.
Some of the major drivers and opportunities for growth of this market include drug combinations of several agents such as sitagliptin and metformin and other drug combinations that are in different stages of clinical and pipeline development. Increase in the prevalence of diabetes and new product launches by major pharmaceutical companies re some of the key drivers for growth in this market. In 2015, Boehringer Ingelheim GmbH launched two new drugs (Synjardy & Glyxambi)for treatment of diabetes mellitus type II. 

Market Analysis and Insights: Global Anti-Diabetic Drugs Market
The global Anti-Diabetic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Diabetic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Diabetic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Diabetic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Diabetic Drugs market.

Global Anti-Diabetic Drugs Scope and Market Size
Anti-Diabetic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Diabetic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biguanides
Sulfonylureas
Meglitinides
Thiazolidinediones
Dipeptidyl Peptidase IV Inhibitors
α-Glucosidase Inhibitors

Segment by Application
Type I Diabetes
Type II Diabetes
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Astra Zeneca
Boehringer Ingelheim
Eli Lilly
Johnson & Johnson
Merck
Novartis
Novo Nordisk
Sanofi
Teva Pharmaceutical Industries

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Diabetic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biguanides
1.2.3 Sulfonylureas
1.2.4 Meglitinides
1.2.5 Thiazolidinediones
1.2.6 Dipeptidyl Peptidase IV Inhibitors
1.2.7 α-Glucosidase Inhibitors
1.3 Market by Application
1.3.1 Global Anti-Diabetic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti-Diabetic Drugs Market Perspective (2016-2027)
2.2 Anti-Diabetic Drugs Growth Trends by Regions
2.2.1 Anti-Diabetic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-Diabetic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Anti-Diabetic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Anti-Diabetic Drugs Industry Dynamic
2.3.1 Anti-Diabetic Drugs Market Trends
2.3.2 Anti-Diabetic Drugs Market Drivers
2.3.3 Anti-Diabetic Drugs Market Challenges
2.3.4 Anti-Diabetic Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti-Diabetic Drugs Players by Revenue
3.1.1 Global Top Anti-Diabetic Drugs Players by Revenue (2016-2021)
3.1.2 Global Anti-Diabetic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Anti-Diabetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-Diabetic Drugs Revenue
3.4 Global Anti-Diabetic Drugs Market Concentration Ratio
3.4.1 Global Anti-Diabetic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Diabetic Drugs Revenue in 2020
3.5 Anti-Diabetic Drugs Key Players Head office and Area Served
3.6 Key Players Anti-Diabetic Drugs Product Solution and Service
3.7 Date of Enter into Anti-Diabetic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-Diabetic Drugs Breakdown Data by Type
4.1 Global Anti-Diabetic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Anti-Diabetic Drugs Forecasted Market Size by Type (2022-2027)

5 Anti-Diabetic Drugs Breakdown Data by Application
5.1 Global Anti-Diabetic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Anti-Diabetic Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti-Diabetic Drugs Market Size (2016-2027)
6.2 North America Anti-Diabetic Drugs Market Size by Type
6.2.1 North America Anti-Diabetic Drugs Market Size by Type (2016-2021)
6.2.2 North America Anti-Diabetic Drugs Market Size by Type (2022-2027)
6.2.3 North America Anti-Diabetic Drugs Market Size by Type (2016-2027)
6.3 North America Anti-Diabetic Drugs Market Size by Application
6.3.1 North America Anti-Diabetic Drugs Market Size by Application (2016-2021)
6.3.2 North America Anti-Diabetic Drugs Market Size by Application (2022-2027)
6.3.3 North America Anti-Diabetic Drugs Market Size by Application (2016-2027)
6.4 North America Anti-Diabetic Drugs Market Size by Country
6.4.1 North America Anti-Diabetic Drugs Market Size by Country (2016-2021)
6.4.2 North America Anti-Diabetic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Anti-Diabetic Drugs Market Size (2016-2027)
7.2 Europe Anti-Diabetic Drugs Market Size by Type
7.2.1 Europe Anti-Diabetic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Anti-Diabetic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Anti-Diabetic Drugs Market Size by Type (2016-2027)
7.3 Europe Anti-Diabetic Drugs Market Size by Application
7.3.1 Europe Anti-Diabetic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Anti-Diabetic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Anti-Diabetic Drugs Market Size by Application (2016-2027)
7.4 Europe Anti-Diabetic Drugs Market Size by Country
7.4.1 Europe Anti-Diabetic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Anti-Diabetic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti-Diabetic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Anti-Diabetic Drugs Market Size by Type
8.2.1 Asia-Pacific Anti-Diabetic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-Diabetic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-Diabetic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-Diabetic Drugs Market Size by Application
8.3.1 Asia-Pacific Anti-Diabetic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-Diabetic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-Diabetic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-Diabetic Drugs Market Size by Region
8.4.1 Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti-Diabetic Drugs Market Size (2016-2027)
9.2 Latin America Anti-Diabetic Drugs Market Size by Type
9.2.1 Latin America Anti-Diabetic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Anti-Diabetic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Anti-Diabetic Drugs Market Size by Type (2016-2027)
9.3 Latin America Anti-Diabetic Drugs Market Size by Application
9.3.1 Latin America Anti-Diabetic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Anti-Diabetic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Anti-Diabetic Drugs Market Size by Application (2016-2027)
9.4 Latin America Anti-Diabetic Drugs Market Size by Country
9.4.1 Latin America Anti-Diabetic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Anti-Diabetic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti-Diabetic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Anti-Diabetic Drugs Market Size by Type
10.2.1 Middle East & Africa Anti-Diabetic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-Diabetic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-Diabetic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-Diabetic Drugs Market Size by Application
10.3.1 Middle East & Africa Anti-Diabetic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-Diabetic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-Diabetic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-Diabetic Drugs Market Size by Country
10.4.1 Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Astra Zeneca
11.1.1 Astra Zeneca Company Details
11.1.2 Astra Zeneca Business Overview
11.1.3 Astra Zeneca Anti-Diabetic Drugs Introduction
11.1.4 Astra Zeneca Revenue in Anti-Diabetic Drugs Business (2016-2021)
11.1.5 Astra Zeneca Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Anti-Diabetic Drugs Introduction
11.2.4 Boehringer Ingelheim Revenue in Anti-Diabetic Drugs Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Anti-Diabetic Drugs Introduction
11.3.4 Eli Lilly Revenue in Anti-Diabetic Drugs Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Anti-Diabetic Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Anti-Diabetic Drugs Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Anti-Diabetic Drugs Introduction
11.5.4 Merck Revenue in Anti-Diabetic Drugs Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-Diabetic Drugs Introduction
11.6.4 Novartis Revenue in Anti-Diabetic Drugs Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Anti-Diabetic Drugs Introduction
11.7.4 Novo Nordisk Revenue in Anti-Diabetic Drugs Business (2016-2021)
11.7.5 Novo Nordisk Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Anti-Diabetic Drugs Introduction
11.8.4 Sanofi Revenue in Anti-Diabetic Drugs Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Anti-Diabetic Drugs Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Anti-Diabetic Drugs Business (2016-2021)
11.9.5 Teva Pharmaceutical Industries Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anti-Diabetic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biguanides
Table 3. Key Players of Sulfonylureas
Table 4. Key Players of Meglitinides
Table 5. Key Players of Thiazolidinediones
Table 6. Key Players of Dipeptidyl Peptidase IV Inhibitors
Table 7. Key Players of α-Glucosidase Inhibitors
Table 8. Global Anti-Diabetic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Anti-Diabetic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Anti-Diabetic Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Anti-Diabetic Drugs Market Share by Regions (2016-2021)
Table 12. Global Anti-Diabetic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Anti-Diabetic Drugs Market Share by Regions (2022-2027)
Table 14. Anti-Diabetic Drugs Market Trends
Table 15. Anti-Diabetic Drugs Market Drivers
Table 16. Anti-Diabetic Drugs Market Challenges
Table 17. Anti-Diabetic Drugs Market Restraints
Table 18. Global Anti-Diabetic Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Anti-Diabetic Drugs Market Share by Players (2016-2021)
Table 20. Global Top Anti-Diabetic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Diabetic Drugs as of 2020)
Table 21. Ranking of Global Top Anti-Diabetic Drugs Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Anti-Diabetic Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Anti-Diabetic Drugs Product Solution and Service
Table 25. Date of Enter into Anti-Diabetic Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-Diabetic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Anti-Diabetic Drugs Revenue Market Share by Type (2016-2021)
Table 29. Global Anti-Diabetic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Anti-Diabetic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Anti-Diabetic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Anti-Diabetic Drugs Revenue Market Share by Application (2016-2021)
Table 33. Global Anti-Diabetic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Anti-Diabetic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Anti-Diabetic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Anti-Diabetic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Anti-Diabetic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Anti-Diabetic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Anti-Diabetic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Anti-Diabetic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Anti-Diabetic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Anti-Diabetic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Anti-Diabetic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Anti-Diabetic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Anti-Diabetic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Anti-Diabetic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anti-Diabetic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Anti-Diabetic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Anti-Diabetic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Anti-Diabetic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Anti-Diabetic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Anti-Diabetic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Anti-Diabetic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Anti-Diabetic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Anti-Diabetic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Anti-Diabetic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anti-Diabetic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Anti-Diabetic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Anti-Diabetic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Anti-Diabetic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 65. Astra Zeneca Company Details
Table 66. Astra Zeneca Business Overview
Table 67. Astra Zeneca Anti-Diabetic Drugs Product
Table 68. Astra Zeneca Revenue in Anti-Diabetic Drugs Business (2016-2021) & (US$ Million)
Table 69. Astra Zeneca Recent Development
Table 70. Boehringer Ingelheim Company Details
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Anti-Diabetic Drugs Product
Table 73. Boehringer Ingelheim Revenue in Anti-Diabetic Drugs Business (2016-2021) & (US$ Million)
Table 74. Boehringer Ingelheim Recent Development
Table 75. Eli Lilly Company Details
Table 76. Eli Lilly Business Overview
Table 77. Eli Lilly Anti-Diabetic Drugs Product
Table 78. Eli Lilly Revenue in Anti-Diabetic Drugs Business (2016-2021) & (US$ Million)
Table 79. Eli Lilly Recent Development
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Anti-Diabetic Drugs Product
Table 83. Johnson & Johnson Revenue in Anti-Diabetic Drugs Business (2016-2021) & (US$ Million)
Table 84. Johnson & Johnson Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Anti-Diabetic Drugs Product
Table 88. Merck Revenue in Anti-Diabetic Drugs Business (2016-2021) & (US$ Million)
Table 89. Merck Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Anti-Diabetic Drugs Product
Table 93. Novartis Revenue in Anti-Diabetic Drugs Business (2016-2021) & (US$ Million)
Table 94. Novartis Recent Development
Table 95. Novo Nordisk Company Details
Table 96. Novo Nordisk Business Overview
Table 97. Novo Nordisk Anti-Diabetic Drugs Product
Table 98. Novo Nordisk Revenue in Anti-Diabetic Drugs Business (2016-2021) & (US$ Million)
Table 99. Novo Nordisk Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Revenue in Anti-Diabetic Drugs Business (2016-2021) & (US$ Million)
Table 103. Sanofi Recent Development
Table 104. Teva Pharmaceutical Industries Company Details
Table 105. Teva Pharmaceutical Industries Business Overview
Table 106. Teva Pharmaceutical Industries Anti-Diabetic Drugs Product
Table 107. Teva Pharmaceutical Industries Revenue in Anti-Diabetic Drugs Business (2016-2021) & (US$ Million)
Table 108. Teva Pharmaceutical Industries Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Diabetic Drugs Market Share by Type: 2020 VS 2027
Figure 2. Biguanides Features
Figure 3. Sulfonylureas Features
Figure 4. Meglitinides Features
Figure 5. Thiazolidinediones Features
Figure 6. Dipeptidyl Peptidase IV Inhibitors Features
Figure 7. α-Glucosidase Inhibitors Features
Figure 8. Global Anti-Diabetic Drugs Market Share by Application: 2020 VS 2027
Figure 9. Type I Diabetes Case Studies
Figure 10. Type II Diabetes Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-Diabetic Drugs Report Years Considered
Figure 13. Global Anti-Diabetic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Anti-Diabetic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Anti-Diabetic Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Anti-Diabetic Drugs Market Share by Regions (2022-2027)
Figure 17. Global Anti-Diabetic Drugs Market Share by Players in 2020
Figure 18. Global Top Anti-Diabetic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Diabetic Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Anti-Diabetic Drugs Revenue in 2020
Figure 20. Global Anti-Diabetic Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Anti-Diabetic Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Anti-Diabetic Drugs Market Share by Type (2016-2027)
Figure 24. North America Anti-Diabetic Drugs Market Share by Application (2016-2027)
Figure 25. North America Anti-Diabetic Drugs Market Share by Country (2016-2027)
Figure 26. United States Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Anti-Diabetic Drugs Market Share by Type (2016-2027)
Figure 30. Europe Anti-Diabetic Drugs Market Share by Application (2016-2027)
Figure 31. Europe Anti-Diabetic Drugs Market Share by Country (2016-2027)
Figure 32. Germany Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Anti-Diabetic Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Anti-Diabetic Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Anti-Diabetic Drugs Market Share by Region (2016-2027)
Figure 42. China Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Anti-Diabetic Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Anti-Diabetic Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Anti-Diabetic Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Anti-Diabetic Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Anti-Diabetic Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Anti-Diabetic Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Anti-Diabetic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Astra Zeneca Revenue Growth Rate in Anti-Diabetic Drugs Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Anti-Diabetic Drugs Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Anti-Diabetic Drugs Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Anti-Diabetic Drugs Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Anti-Diabetic Drugs Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Anti-Diabetic Drugs Business (2016-2021)
Figure 67. Novo Nordisk Revenue Growth Rate in Anti-Diabetic Drugs Business (2016-2021)
Figure 68. Sanofi Revenue Growth Rate in Anti-Diabetic Drugs Business (2016-2021)
Figure 69. Teva Pharmaceutical Industries Revenue Growth Rate in Anti-Diabetic Drugs Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---